Karyopharm Therapeut
(KPTI)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2019 | 12-2018 | 12-2017 | 12-2016 | 12-2015 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -199,590 | -178,407 | -128,984 | -109,577 | -118,181 |
| Depreciation Amortization | 6,785 | 2,184 | 1,900 | 1,916 | 2,412 |
| Accounts receivable | -7,862 | N/A | N/A | N/A | N/A |
| Accounts payable and accrued liabilities | -3,301 | -1,380 | 909 | 945 | -2,426 |
| Other Working Capital | -13,308 | -169 | 32,962 | 987 | 4,683 |
| Other Operating Activity | 26,454 | 18,655 | 19,496 | 21,338 | 19,483 |
| Operating Cash Flow | $-190,822 | $-159,117 | $-73,717 | $-84,391 | $-94,029 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -206 | -2,363 | -62 | -70 | -1,416 |
| Purchase Of Investment | -178,489 | -242,811 | -98,374 | -134,700 | -305,192 |
| Sale Of Investment | 257,145 | 137,510 | 115,544 | 159,365 | 215,867 |
| Other Investing Activity | 0 | 0 | 0 | 0 | -82 |
| Investing Cash Flow | $78,450 | $-107,664 | $17,108 | $24,595 | $-90,823 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | 166,885 | N/A | N/A | N/A |
| Common Stock Issued | 50,696 | 149,224 | 75,743 | 51,203 | 92,700 |
| Other Financing Activity | 73,609 | 0 | 0 | -39 | 0 |
| Financing Cash Flow | $124,305 | $316,109 | $75,743 | $51,164 | $92,700 |
| Exchange Rate Effect | 19 | -78 | 211 | -66 | -99 |
| Beginning Cash Position | 118,737 | 69,487 | 50,142 | 58,840 | 150,609 |
| End Cash Position | 130,689 | 118,737 | 69,487 | 50,142 | 58,358 |
| Net Cash Flow | $11,952 | $49,250 | $19,345 | $-8,698 | $-92,251 |
| Free Cash Flow | |||||
| Operating Cash Flow | -190,822 | -159,117 | -73,717 | -84,391 | -94,029 |
| Capital Expenditure | -206 | -2,363 | -62 | -70 | -1,416 |
| Free Cash Flow | -191,028 | -161,480 | -73,779 | -84,461 | -95,445 |